Skip to main content
Back to Valor Equity Partners

Valor Equity Partners's Pharmaceutical Portfolio

Browse 4 Pharmaceutical companies funded by Valor Equity Partners. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
4
Total Funding in Pharmaceutical
$455.0M

Pharmaceutical Portfolio Companies (4)

Export
Health CareMedicalPharmaceuticalTherapeutics

Holobiome is an owner and operator of a therapeutic company intended to treat diseases of the enteric and central nervous systems.

Cambridge, United States
July 2026
$10.0M
Seed

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife SciencePharmaceutical

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

Exton, United States
February 2025
$75.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Chicago, United States
November 2022
$270.0M
Series D

Founder Contacts

41,000+ verified contacts

BiotechnologyPetPharmaceuticalVeterinary

Loyal is a clinical-stage veterinary medicine company dedicated to extending the healthy lifespan of senior dogs.

San Francisco, United States
February 2026
$100.0M
Series C

Founder Contacts

41,000+ verified contacts

Explore Valor Equity Partners's Full Portfolio

View all companies funded by Valor Equity Partners across every industry and funding stage.

View Full Valor Equity Partners Portfolio